Name
Lumomed Eesti OÜ
Registry code
12500216
VAT number
EE102135912
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
05.07.2013 (11)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47741 - Retail sale of medical and orthopaedic goods in specialised stores
164 813 €
7 034 €
4%
705 €
(estimate is approximate)
199 549 €
3
Submitted
No tax arrears
4%
3%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Jeanne Palokangas 09.11.1975 (48) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
| Juha Tapio Palokangas 25.04.1968 (56) | - | Board member | - | Founder |
| Lassi Pekka Palokangas 26.03.1974 (50) | - | - | - | Founder |
| 2019 01.04.2020 | 2020 09.07.2021 | 2021 05.07.2022 | 2022 10.07.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 79 034 € | 418 740 € | 226 892 € | 316 728 € | 164 813 € |
| Net profit (loss) for the period | 59 871 € | 89 584 € | 2 587 € | 34 984 € | 7 034 € |
| Profit Margin | 76% | 21% | 1% | 11% | 4% |
| Current Assets | 74 580 € | 171 467 € | 141 392 € | 185 361 € | 195 555 € |
| Fixed Assets | 11 108 € | 51 451 € | 53 074 € | 48 128 € | 44 386 € |
| Total Assets | 85 688 € | 222 918 € | 194 466 € | 233 489 € | 239 941 € |
| Current Liabilities | 16 719 € | 64 365 € | 33 934 € | 37 974 € | 40 392 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 68 969 € | 158 553 € | 160 532 € | 195 515 € | 199 549 € |
| Employees | 1 | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 40 613.46 € | 447.37 € | 1 885.16 € | 2 |
| 2023 Q4 | 40 995.26 € | 3 114.76 € | 2 563.76 € | 2 |
| 2023 Q3 | 91 603.7 € | 2 001.26 € | 3 066.95 € | 2 |
| 2023 Q2 | 72 674.56 € | 4 569.09 € | 3 732.63 € | 2 |
| 2023 Q1 | 49 536.32 € | 2 215.25 € | 3 030.83 € | 2 |
| 2022 Q4 | 55 592.93 € | - | 3 092.43 € | 2 |
| 2022 Q3 | 103 304.9 € | - | 3 856.83 € | 2 |
| 2022 Q2 | 155 627.91 € | - | 4 037.27 € | 2 |
| 2022 Q1 | 145 959.04 € | 2 474.51 € | 3 982.59 € | 2 |
| 2021 Q4 | 66 358.29 € | 1 003.62 € | 2 708.01 € | 2 |
| 2021 Q3 | 30 236.59 € | 43.67 € | 1 584.07 € | 2 |
| 2021 Q2 | 55 240.66 € | 2 047.83 € | 2 043.03 € | 1 |
| 2021 Q1 | 138 506.3 € | 490.19 € | 2 252.55 € | 3 |
| 2020 Q4 | 153 798.97 € | 2 263.82 € | 2 408.04 € | 3 |
| 2020 Q3 | 146 047.69 € | - | 2 515.5 € | 3 |
| 2020 Q2 | 327 893.39 € | 2 389.94 € | 2 544.86 € | 3 |
| 2020 Q1 | 105 720.47 € | 213.9 € | 1 864.98 € | 3 |
